Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma
- PMID: 29971569
- DOI: 10.1007/s11060-018-2936-z
Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma
Abstract
Introduction: The current study aimed to assess whether childhood-onset craniopharyngioma patients suffer from symptoms of apathy, as assessed by patients themselves and their close others. We further analyzed whether apathy scores are related to symptoms of depression.
Methods: Childhood-onset craniopharyngioma patients (n = 35, 16 female, median age = 22) and matched healthy controls (n = 35, 19 female, median age = 21) were asked to complete self-ratings of the Apathy Evaluation Scale, whereas informant-ratings were obtained from their close others. Depression was assessed by self-ratings using the German version of the Center for Epidemiological Studies Depression Scale. As primary outcome measures, self- and informant-rated apathy scores were compared between patients and healthy controls. As secondary outcome measures, differences between self- and informant-rated apathy within the single groups and associations between apathy and depression were analyzed.
Results: Compared to healthy controls, patients displayed significantly higher apathy levels in informant-ratings (medianpatients = 18, mediancontrols = 12, p = .021), but not in self-ratings (medianpatients = 11, mediancontrols =12, p = .68). In patients, there was a significant discrepancy between self- and informant-rated apathy and self-rated apathy was related to symptoms of depression.
Conclusions: This is the first study to show that childhood-onset craniopharyngioma patients may be at high risk for apathy. Noteworthy, apathy levels in the patient group were judged to be high by their close others but not by the patients themselves, indicating that many patients were not fully aware of their impairments. As apathy is associated with numerous adverse outcomes affecting everyday life and vocational opportunities, future investigations are needed to identify specific risk factors for apathy. Clinical Trial Registration No: NCT00258453.
Keywords: Apathy; Brain tumors; Craniopharyngioma; Depression; Hypothalamus; Pituitary.
Similar articles
-
Health related quality of life and psychological outcome in patients treated for craniopharyngioma in childhood.J Pediatr Endocrinol Metab. 2006 Jan;19(1):15-24. doi: 10.1515/jpem.2006.19.1.15. J Pediatr Endocrinol Metab. 2006. PMID: 16509524 Clinical Trial.
-
Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy.Brain Inj. 2012;26(3):270-81. doi: 10.3109/02699052.2011.648709. Brain Inj. 2012. PMID: 22372414
-
Everyday cognitive function after craniopharyngioma in childhood.Pediatr Neurol. 2006 Jan;34(1):13-9. doi: 10.1016/j.pediatrneurol.2005.06.002. Pediatr Neurol. 2006. PMID: 16376272
-
Craniopharyngiomas Primarily Involving the Hypothalamus: A Model of Neurosurgical Lesions to Elucidate the Neurobiological Basis of Psychiatric Disorders.World Neurosurg. 2018 Dec;120:e1245-e1278. doi: 10.1016/j.wneu.2018.09.053. Epub 2018 Sep 18. World Neurosurg. 2018. PMID: 30240857
-
High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.Clin Endocrinol (Oxf). 2005 Feb;62(2):197-204. doi: 10.1111/j.1365-2265.2004.02196.x. Clin Endocrinol (Oxf). 2005. PMID: 15670196 Review.
Cited by
-
Cognitive and social functions of craniopharyngioma and germ cell tumor differ in patients with and without apathy.PCN Rep. 2025 Feb 23;4(1):e70068. doi: 10.1002/pcn5.70068. eCollection 2025 Mar. PCN Rep. 2025. PMID: 39996134 Free PMC article.
-
Hypothalamic syndrome.Nat Rev Dis Primers. 2022 Apr 21;8(1):24. doi: 10.1038/s41572-022-00351-z. Nat Rev Dis Primers. 2022. PMID: 35449162 Review.
-
Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma.Sci Rep. 2025 Mar 19;15(1):9407. doi: 10.1038/s41598-025-94384-5. Sci Rep. 2025. PMID: 40108339 Free PMC article.
-
Assessment of quality of life in patients with craniopharyngioma and identification of risk factors for compromised overall wellness.Arch Endocrinol Metab. 2023 Nov 17;68:e230001. doi: 10.20945/2359-4292-2023-0001. Arch Endocrinol Metab. 2023. PMID: 37988666 Free PMC article.
-
Craniopharyngioma: A comprehensive review of the clinical presentation, radiological findings, management, and future Perspective.Heliyon. 2024 May 31;10(11):e32112. doi: 10.1016/j.heliyon.2024.e32112. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38961911 Free PMC article. Review.
References
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials